Status:
UNKNOWN
Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Thalassemia Major
Acute Leukemia
Eligibility:
All Genders
2-18 years
Brief Summary
Objective: To longitudinally track the dynamic changes in the survival quality of pediatric patients after hematopoietic stem cell transplantation at different time points within 1 year post-transplan...
Detailed Description
Objective: longitudinal tracking hematopoietic stem cell transplantation in 1 years after transplantation in different time points of the quality of life dynamic change trajectory, analyze the factors...
Eligibility Criteria
Inclusion
- children aged between 0 and 18 years old who will receive a stem cell infusion
- conscious, have a certain level of cognitive ability and be able to express their physical and psychological state accurately
- If the child is under 8 years old, their caregiver should have a primary school or higher education level with sufficient reading comprehension and expression abilities
- both the child and the legal guardian are informed and consent to participate in the study
Exclusion
- the child has a history of mental illness
- the child has severe organ failure or other serious complications involving the heart, brain, lungs, liver, kidneys, and other organs
Key Trial Info
Start Date :
October 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06026839
Start Date
October 30 2023
End Date
December 31 2024
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510030